Health Condition 1: null- Bronchial Asthma
Conditions
Interventions
Intervention1: Kanakasava, Trivrit churna: 1.Kanakasava 20ml twice daily with luke warm water for 12 weeks.
2.Trivrit churna 3gm during bed time with luke warm water for 12 weeks.
Control Intervention
Sponsors
Central Council for Research in Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either sex with age between 18 to 60 years. 2.Patients with stable Bronchial Asthma (Tamaka Swasa) (as per GINA Guideline) for at least 6 weeks prior to study entry. 3.Subjects with intermittent & mild persistent controlled bronchial asthma & show >12 % improvement in FEV1 after bronchodilator. 4.FEV1 of > 80% of predicted value. 5.Patients willing to participate and written consent.
Exclusion criteria
Exclusion criteria: 1.Patients with FEV1 2.Patients with evidence of malignancy. 3.Patients with uncontrolled Diabetes Mellitus of HbA1c >7.5%. 4.Patients with unstable cardio vascular disease. 5.Patients with uncontrolled hypertension 6.Patients who needs rescue medication daily e.g. Salbutamol inhaler. 7.Patients suffering from other major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders, etc.) 8.Patients with concurrent serious hepatic disorder or Renal Disorders 9.Pulmonary disease other than bronchial asthma. 10.Smoker/alcoholics and/or drug abusers. 11.H/o hypersensitivity to the trial drug or any of its ingredients. 12.Patients who have completed participation in any other clinical trial during the past six (06) months. 13.Pregnancy or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome Measure â?¢Change in Asthma Control Questionnaire (ACQ) from the baseline, at the end of 4th week, 8th week & 12th week. â?¢PEFR assessments of personal best peak flow every 15 days to the end of the trialTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcome Measures â?¢Change in St Georgeâ??s Respiratory Questionnaire (SGRQ-C) from the baseline, at the end of 4th week, 8th week & 12th weekTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr R Kumara Swamy
National Ayurveda Research Institute for Vector Borne Diseases(CCRAS)
Outcome results
None listed